CoChat

Rhinitis and asthma represent hot topics for Allergy

Open access
Bousquet, J., Bieber, T., Fokkens, W., Kowalski, M. L., Humbert, M., Niggemann, B., Simon, H.‐U. · 2009 · Allergy
Cited by 54

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Rhinitis and asthma represent hot topics and there are still more questions than answers (1). We urgently need a common international approach, in particular for severe diseases (2). In this issue of the journal, Cooper et al. (3) report on asthma in Latin America and show that this is a public health challenge with interesting research opportunities. The global map of the prevalence of symptoms of rhinoconjunctivitis in children is reported in this issue of the journal by the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three (4). Interesting results are found since elevated prevalence rates are found around the world and not only in developed countries. Important research questions in allergy and related diseases is a new series of the Journal attempting to identify topics of interest for future programs (5). Among the first question published, nonallergic rhinitis (6) appears to be of great relevance due to the very large number of patients (probably hundreds of million around the world) (7, 8), the difficulty to understand the mechanisms (9–18), the importance of occupational agents (19), the links with lower airway disease (20–22), under diagnosis (23), and the lack of adequate treatment. It is important to differentiate nonallergic rhinitis from chronic rhinosinusitis (24). It is possible that the stress response is dysregulated in nonallergic rhinitis as it has been proposed in a challenging hypothesis in asthma (25). Novel therapeutic approaches are needed for the control of nonallergic patients. In this issue of the journal it has been reported that topical corticosteroids down-regulate COX-1 positive cells in nasal polyps (26). The relationship between chronic rhinosinusitis and asthma is still unclear and it is important to find predictors of bronchial hyperresponsiveness in patients with chronic rhinosinusitis (27). Airway remodeling is another important topic and it is needed to differentiate persistence vs progression (28–30). The treatment of severe asthma by anti-IgE is still a hot topic (31–33) including the cost-effectiveness of expensive interventions (34). In the present issue, Humbert et al. (35) show that patients who achieve greatest benefit for their asthma experience with omalizumab therapy also experience greatest benefit for rhinitis. This is the first time that such links are found. The socioeconomic burden of allergic diseases and asthma need to be re-emphasized (36) and Simoens et al. (37) present recent data on the pharmacoeconomics of allergic rhinitis in this issue of the journal. 2008 was the year of the Olympic games, and Allergy published a series (38–42) on the subject with a key paper from China proposing the methods to be used to prevent air pollution during the period of the games in Beijing (42). An important meeting with the International Olympic Committee was reported in another journal (43). Air pollution (44) as well as with climate changes represent an important issue for the future of allergic diseases and more studies are needed to appreciate their importance (45, 46). Ozone changes are associated with some inflammatory mechanisms of allergic diseases, but it had not been reported before that they are also involved in total IgE levels (47). Guidelines are part of our daily practice. The journal has published in 2008 important guidelines on paediatric asthma (48) and allergic rhinitis (ARIA) (49). These guidelines were based on a simple evidence-based system which needs to be improved in order to include safety, patient's views and costs (50). Other practice parameters have been published in rhinitis in 2008 (51). There is a need for guidelines harmonization and for clear-cut methodology for guideline development (52). They should be carefully developed and should follow a precise methodology in order to be widely applicable and avoid harm for patients (53). Moreover, these guidelines are usually source documents which need to be summarized in pocket guides for primary care physicians (49, 54), the cornerstone of rhinitis and asthma diagnosis and treatment (55, 56). The primary prevention of asthma and allergy is essential (57–60) and the journal is proud that the first national prevention program, the Finnish program, has been published in June (61). The tertiary prevention of asthma is still a matter of debate. The most recent Cochrane meta-analysis concerning house dust mite prevention has been published in June (62). It has raised a very interesting debate published in this issue of the journal (63–65). The European Union networks and programs need to be publicized and we are proud to publish studies and positions from GA2LEN (38, 39, 66–69), INDEX (70), CREATE (71) and EUROPREVALL (72).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1398-9995.2008.01954.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 54

Metadata

Authors
Bousquet, J., Bieber, T., Fokkens, W., Kowalski, M. L., Humbert, M., Niggemann, B., & Simon, H. ‐.
Venue
Allergy
Publisher
Wiley
Published
2008-12-23
Volume
64
Issue
1
Pages
1-4
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W2000099703
Cited by
54
References
9
FWCI
2.03
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rhinitis and asthma represent hot topics for Allergy. https://app.cochat.ai/papers/10.1111/j.1398-9995.2008.01954.x
The paper
Bousquet, J., Bieber, T., Fokkens, W., Kowalski, M. L., Humbert, M., Niggemann, B., & Simon, H. ‐. (2009). Rhinitis and asthma represent hot topics for Allergy. Allergy. https://doi.org/10.1111/j.1398-9995.2008.01954.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.